PTC Therapeutics, Inc. (PTCT) Social Stream



PTC Therapeutics, Inc. (PTCT): $42.63

2.04 (+5.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PTCT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 506

in industry

Ptc Therapeutics Inc (PTCT) Price Targets From Analysts

Use the tables below to see what analysts covering Ptc Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
12 $90 $45 $61.58 $40.59 51.71%

The Trend in the Analyst Price Target


PTCT's average price target has moved up $1.38 over the prior 75 days.

Over the past 178 days, PTCT's average upside potential has been 8%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-25 12 90 45 61.58 63.53 -3.07%
2020-11-23 12 90 45 61.58 62.24 -1.06%
2020-11-19 12 90 45 61.58 62.83 -1.99%
2020-10-30 12 90 45 61.25 52.19 17.36%
2020-09-30 10 86 45 60.20 46.75 28.77%
2020-09-11 10 86 45 60.20 NA NA%
2020-08-21 10 86 46 60.30 NA NA%
2020-08-10 9 86 46 60.00 NA NA%
2020-08-07 9 86 46 61.44 NA NA%
2020-07-17 9 86 50 62.22 NA NA%
2020-07-15 9 85 50 62.00 NA NA%
2020-07-02 9 85 50 61.22 NA NA%
2020-06-22 9 85 45 60.44 NA NA%
2020-06-20 9 85 45 60.44 NA NA%
2020-05-31 9 85 45 60.44 NA NA%

PTCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.62 3 4 6 0 0 13

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PTCT as an investment opportunity.

  • Ptc Therapeutics Inc's variance in analysts' estimates is less than 11.48% of all US stocks.
  • PTCT has a greater number of analysts covering the stock than 90.74% of Pharmaceutical Products stocks.
  • Ptc Therapeutics Inc's average analyst price target is greater than 84.43% of Pharmaceutical Products stocks.
  • Ptc Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 83.4% of stocks in the mid market cap category.

Stocks similar to Ptc Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NKTR, BHC and FOLD.

Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7261 seconds.